Core Med Tech Development ApS: Financial statements 2017
CVR: 37703788
Source: annual report 2017, Danish Business Authority
23/05/2016 – 30/04/2017
Core Med Tech Development ApS (CVR 37703788) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -5,025 and a net result of DKK 2,637,388. Equity in the 2017 report amounted to DKK 4,948,160. The solvency ratio was 29.3%.
- Gross Profit
- DKK -5,025
- Profit/Loss
- DKK 2,637,388
- Equity
- DKK 4,948,160
- Total Assets
- DKK 16,913,050
Keep an eye on Core Med Tech Development ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of October 17, 2017, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has been appointed auditor of Core Med Tech Development ApS.
As of October 17, 2017, REVISIONSFIRMAET SLOTH REGISTRERETREVISIONSAKTIESELSKAB has stepped down as auditor of Core Med Tech Development ApS.
As of February 16, 2017, REVISIONSFIRMAET SLOTH REGISTRERETREVISIONSAKTIESELSKAB has been appointed auditor of Core Med Tech Development ApS.
About Core Med Tech Development ApS
Core Med Tech Development ApS is a Danish company of the type Anpartsselskab based in Allerød, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Steffen Vogel and Christian Schärfe Baltzer-Thomsen. The company is owned by SASSER G HOLDING ApS and Baltho Holding ApS. In 2025, the company reported a gross profit of DKK -220,933 and a net result of DKK -99,037 compared with DKK 1,645,725 the year before. Equity in the 2025 report amounted to DKK 15,007,343.